Streptococcus pneumoniae virulence factors and their clinical impact: An update

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 24, Issue 8, 2006, Pages 512-517

  García Suárez, María Del Mar ^a   Vázquez, Fernando ^a,b   Méndez, Francisco J ^a,c  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL MONTE NARANCO   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Diagnosis; Streptococcus pneumoniae; Vaccines; Virulence factors

Indexed keywords

CYTOLYSIN; MEMBRANE PROTEIN; PNEUMOCOCCUS VACCINE; PNEUMOLYSIN; VIRULENCE FACTOR;

BACTERIAL STRAIN; DIAGNOSTIC PROCEDURE; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; REVIEW; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; URINALYSIS; VIRULENCE;

EID: 33751007874     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13092469     Document Type: Review

References (66)

1. Girard MP, Cherian T, Pervikov Y, Kieny MP. A review of vaccine research and development: Human acute respiratory infections. Vaccine. 2005;50:5708-24.
2. Reinert RE. Pneumococcal conjugate vaccines - a European perspective. Int J Med Microbiol. 2004;94:277-94.
3. Madhi SA, Klugman KP, the Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811-3.
4. Zar HJ. Pneumonia in HIV-infeeted and HIV-uninfected children in developing countries: epidemiology, clinical features, and management. Curr Opin Pulm Med. 2004;10:176-82.
5. Fenoll A, Asensio G, Jado I, Berron S, Camacho MT, Ortega M, et al. Antimicrobial susceptibility and pneumococcal serotypes. J Antimicrob Chemother. 2002;50 Suppl:13-9.
6. Granizo JJ, Aguilar L, Casal J, García-Rey C, Dal-Re R, Baquero F. 2000. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother. 2000;46:767-73.
7. Reinert RR, Ringelstein A, Van der Linden M, Cil MY, Al-Lahham A, Schmitz F. Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe. J Clin Microbiol. 2005;43:1294-00.
8. Guillemot D, Varon E, Bernede C, Weber P, Henriet L, Simon S, et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae. Clin Infect Dis. 2005;41:930-8.
9. Frazao N, Brito-Avo A, Simas C, Saldanha J, Mato R, Nunes S, et al. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centers in Lisbon. Pediatr Infect Dis J. 2005;24:243-52.
10. Bogaert D, Van Belkum A, Sluijter M, Luijendijk A, De Groot R, Rumke HC, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet. 2004;363:1871-2.
11. Hentzer M, Givskov M. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections J Clin Invest. 2003;112:1300-7.
12. Jefferies JM, Smith A, Clarke SC, Dowson C, Mitchell TJ. Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching. J Clin Microbiol. 2004;42:5681-8.
13. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis. 2005;5:83-93.
14. Hanage WP, Kaijalainen TH, Syrjanen RK, Auranen K, Leinonen M, Makela PH, et al. Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland. Infect Immun. 2005;73:431-5.
15. Pettigrew MM, Fennie KP. Genomic subtraction followed by dot blot screening of Streptococcus pneumoniae clinical and carriage isolates identifies genetic differences associated with strains that cause otitis media. Infect Immun. 2005;73:2805-11.
16. Hammerschmidt S, Wollf S, Hocke A, Rosseau S, Muller E, Rohde M. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73:4653-67.
17. Briles DB, Novak L, Hotomi M, Van Ginkel FW, King J. Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci. Infect Immun. 2005;73:6945-51.
18. Jedrzejas MJ. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev. 2001;65:187-207.
19. Austrian R. Pneumococcal otitis media and pneumococcal vaccines, a historical perspective. Vaccine. 2001;19 Suppl:71-7.
20. Briles DE, Hollingshead SK, Nabors GS, Paton JC, Brooks-Walter A. The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine. 2000;19 Suppl:87-95.
21. Bogaert D, Hermansa PWM, Adrian PV, Rümke HC, De Groot R. Pneumococcal vaccines: an update on current strategies. Vaccine. 2004;22:2209-20.
22. López R, García E. Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage. FEMS Microbiol Rev. 2004; 28:553-80.
23. Lee CJ, Lee LH, Gu XX. Mucosal immunity induced by pneumococcal glycoconjugate. Crit Rev Microbiol. 2005;31:137-44.
24. Harris SL, Park MK, Nahm MH, Diamond B. Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae. Infect Immun. 2000;68:5778-84.
25. Kim JH, Seo H, Han SH, Lin J, Park MK, Sorensen UB, et al. Monoacyl lipoteichoic acid from pneumococci stimulates human cells but not mouse cells. Infect Immun. 2005;73:834-40.
26. Boneca IG. The role of peptidoglycan in pathogenesis. Curr Opin Microbiol. 2005;8:46-53.
27. Carneiro LA, Travassos LH, Philpott DJ. Innate immune recognition of microbes through Nod1 and Nod2: implications for disease. Microbes Infect. 2004;6:609-16.
28. Nabors GS, Braun PA, Herrmann DJ, Heise ML, Pyle DJ, Gravenstein S, et al. Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies. Vaccine. 2000;18:1743-54.
29. Coats MT, Benjamin WH, Hollingshead SK, Briles DE. Antibodies to the pneumococcal surface protein A, PspA, can be produced in splenectomized and can protect splenectomized mice from infection with Streptococcus pneumoniae. Vaccine. 2005;23:4257-62.
30. Gor DO, Ding X, Briles DE, Jacobs MR, Greenspan NS. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect Immun. 2005;73:1304-12.
31. Berry AM, Paton JC. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun. 2000;68:133-40.
32. Ogunniyi AD, Woodrow MC, Poolman JT, Paton JC. Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect Immun. 2001;69:5997-6003.
33. Ling E, Feldman G, Portnoi M, Dagan R, Overweg K, Mulholland F, et al. Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin Exp Immunol. 2004;138:290-8.
34. Guiral S, Mitchell TJ, Martin B, Claverys JP. Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc Natl Acad Sci. 2005;102:8710-5.
35. Seo JY, Seong SY, Ahn BY, Kwon IC, Chung H, Jeong SY. Cross-protective immunity of mice induced by oral immunization with pneumococcal surface adhesin A encapsulated in microspheres. Infect Immun. 2002;70:1143-9.
36. Jomaa M, Yuste J, Paton JC, Jones C, Dougan G, Brown JS. Antibodies to the iron uptake ABC transporter lipoproteins PiaA and PiuA promote opsonophagocytosis of Streptococcus pneumoniae. Infect Immun. 2005;73:6852-9.
37. Overweg K, Kerr A, Sluijter M, Jackson MH, Mitchell TJ, De Jong AP, et al. The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses. Infect Immun. 2000;68:4180-8.
38. Long JP, Tong HH, DeMaria TF. Immunization with native or recombinant Streptococcus pneumoniae neuraminidase affords protection in the chinchilla otitis media model. Infect Immun. 2004;72:4309-13.
39. García-Suárez MM, Cima-Cabal MD, Flórez N, García P, Astudillo A, Cernuda-Cernuda R, et al. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. Infect Immun. 2004;72:4534-40.
40. Cockeran R, Anderson R, Feldman C. Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Arch Immunol Ther Exp. 2005;53:189-98.
41. Kadioglu A, Andrew PW. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol. 2004;25:143-9.
42. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;4:783-801.
43. Rapola S, Jantti V, Eerola M, Makela PH, Kayhty H, Kilpi T. Anti-PsaA and the risk of pneumococcal AOM and carriage. Vaccine. 2003;21:3608-13.
44. McCool TL, Cate TR, Tuomanen EI, Adrian P, Mitchell TJ, Weiser JN. Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect Immun. 2003;71: 5724-32.
45. Holmlund E, Quiambao B, Ollgren J, Nohynek H, Kayhty H. Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage. Vaccine. 2006;24:57-65.
46. Palaniappan R, Singh S, Singh UP, Sakthivel SKK, Ades EW, Briles DE, et al. Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage. Infect Immun. 2005;73:1006-13.
47. Johnson SE, Dykes JK, Jue DL, Sampson JS, Carlone GM, Ades EW. Inhibition of pneumococcal carriage in mice by subcutaneous immunization with peptides from the common surface protein pneumococcal surface adhesina. J Infect Dis. 2002;185:489-96.
48. Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, Malley R. Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med. 2005;2(1):e15.
49. Malley R, Lipsitch M, Stack A, Saladino R, Fleisher G, Pelton S, et al. Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci. Infect Immun. 2001;69:4870-3.
50. +T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci. 2005;102:4848-53.
51. Cima-Cabal MD, Vázquez F, De los Toyos JR, Méndez FJ. Rapid and reliable identification of S. pneumoniae isolates by pneumolysin mediated agglutination. J Clin Microbiol. 1999;37:1964-6.
52. Slotved HC, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F. Simple, rapid latex agglutination test for serotyping of pneumococci (Pneumotest-Latex). J Clin Microbiol. 2004;42:2518-22.
53. Petti CA, Woods CW, Reller LB. Streptococcus pneumoniae antigen test using positive blood culture bottles as an alternative method to diagnose pneumococcal bacteremia. J Clin Microbiol. 2005;43:2510-2.
54. Cima-Cabal MD, Méndez FJ, Vázquez F, Aranaz C, Rodríguez-Álvarez J, García-García JM, et al. Immunodetection of pneumolysin in human urine by ELISA. J Microbiol Methods. 2003;54:47-55.
55. Leeming JP, Cartwright K, Morris R, Martin SA, Smith MD on behalf of the South-West Pneumococcus Study Group. Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection. J Clin Microbiol. 2005;43:4972-6.
56. Díaz-González M, González-García MB, Costa-García A. Detection of pneumolysin in human urine using an immunosensor on screen-printed carbon electrodes. Sensors and Actuators B. 2006;113:1005-11.
57. Menezes-Martins LF, Menezes-Martins JJ, Michaelsen VS, Aguiar BB, Ermel T, Machado DC. Diagnosis of parapneumonic pleural effusion by polymerase chain reaction in children. J Pediatr Surg. 2005;40:1106-10.
58. Falguera M, López A, Nogues A, Porcel JM, Rubio-Caballero M. Evaluation of the polymerase chain reaction method for detection of Streptococcus pneumoniae DNA in pleural fluid samples. Chest. 2002;122:2212-6.
59. Yang S, Lin S, Khalil A, Gaydos C, Nuemberger E, Juan G, et al. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol. 2005;43:3221-6.
60. Saukkoriipi A, Leskela K, Herva E, Leinonen M. Streptococcus pneumoniae in nasopharyngeal secretions of healthy children: comparison of real-time PCR and culture from STGG-transport medium. Mol Cell Probes. 2004;3:147-53.
61. Cima-Cabal MD, Méndez FJ, Vázquez F, García- Suárez MM, De los Toyos JR. A specific and ultrasensitive chemiluminescent sandwich ELISA tests for the detection and quantitation of pneumolysin. J Immunoassay Immunochem. 2001;22:99-112.
62. Seki M, Yamashita Y, Torigoe H, Tsuda H, Sato S, Maeno M. Loop-mediated isothermal amplification method targeting the lytA gene for detection of Streptococcus pneumoniae. J Clin Microbiol. 2005;4:1581-6.
63. Batt SL, Charalambous BM, McHugh TD, Martin S, Gillespie SH. Novel PCR-restriction fragment length polymorphism method for determining serotypes or serogroups of Streptococcus pneumoniae isolates. J Clin Microbiol. 2005;43:2656-61.
64. O'Halloran DM, Cafferkey MT. Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine. J Clin Microbiol. 2005;43:3487-90.
65. Kong F, Wang W, Tao J, Wang L, Wang Q, Sabananthan A, et al. A molecular-capsular-type prediction system for 90 Streptococcus pneumoniae serotypes using partial cpsA-cpsB sequencing and wzy- or wzx-specific PCR. J Med Microbiol. 2005;54:351-6.
66. Hanage WP, Kaijalainen T, Herva E, Saukkoriipi A, Syrjanen R, Spratt BG. Using multilocus sequence data to define the pneumococcus. J. Bacteriol. 2005;187:6223-30.